41 min listen
Telemedicine for the Care of Hemophilia: What Do We Gain And What Do We Lose?
Telemedicine for the Care of Hemophilia: What Do We Gain And What Do We Lose?
ratings:
Length:
48 minutes
Released:
Jul 27, 2023
Format:
Podcast episode
Description
Telehealth options are assumed to provide added benefit to providers and patients alike, but how much do we really know and understand about telemedicine? Listen in to the latest episode of Global Hemophilia Report as our contributors share how telemedicine has potentially benefited and detracted from hemophilia care across different populations as well as what research must still be done on the rise of telehealth in hemophilia care Contributors: Sativa Rangarajan, Associate Professor of Clinical Haematology Michelle Witkop, DNP, FNP-BC Dr. Roshni Kulkarni, Professor & Former Director Michigan State University Centers For Bleeding And Clotting Disorders Annette von Drygalski, MD, PharmD Senior Advisor: Donna DiMichele, MD Hosted by: Patrick James Lynch Written by: Simantini Karve, PhD Show Notes: Presenting Sponsor: Sanofi Subscribe to the Global Hemophilia Report Connect with the Global Hemophilia Report Global Hemophilia Report on LinkedIn Global Hemophilia Report on Twitter Global Hemophilia Report on Facebook Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook BloodStream on Twitter
Released:
Jul 27, 2023
Format:
Podcast episode
Titles in the series (29)
Inhibitors: Prevention, Eradication, and Lived Experiences: Inhibitor development has long been considered the most significant complication of severe hemophilia, but with the licensure of the first non-factor therapy and a robust pipeline of novel and gene therapeutics being investigated, is it still of... by Global Hemophilia Report